US 11613744
Modified urokinase-type plasminogen activator polypeptides and methods of use
granted A61KA61K38/00
Quick answer
US patent 11613744 (Modified urokinase-type plasminogen activator polypeptides and methods of use) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 77
- CPC classes
- A61K, A61K38/00